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Genome-wide gene expression studies may provide substantial insight into gene activities and biological
pathways differing between tissues and individuals. We investigated such gene expression variation by ana-
lyzing expression profiles in brain tissues derived from eight different brain regions and from blood in
12 monkeys from a biomedically important non-human primate model, the vervet (Chlorocebus aethiops
sabaeus). We characterized brain regional differences in gene expression, focusing on transcripts for
which inter-individual variation of expression in brain correlates well with variation in blood from the same
individuals. Using stringent criteria, we identified 29 transcripts whose expression is measurable, stable,
replicable, variable between individuals, relevant to brain function and heritable. Polymorphisms identified
in probe regions could, in a minority of transcripts, confound the interpretation of the observed inter-
individual variation. The high heritability of levels of these transcripts in a large vervet pedigree validated
our approach of focusing on transcripts that showed higher inter-individual compared with intra-individual
variation. These selected transcripts are candidate expression Quantitative Trait Loci, differentially regulat-
ing transcript levels in the brain among individuals. Given the high degree of conservation of tissue
expression profiles between vervets and humans, our findings may facilitate the understanding of regional
and individual transcriptional variation and its genetic mechanisms in humans. The approach employed
here—utilizing higher quality tissue and more precise dissection of brain regions than is usually possible
in humans—may therefore provide a powerful means to investigate variation in gene expression relevant
to complex brain related traits, including human neuropsychiatric diseases.
INTRODUCTION
Gene expression measures provide an intermediate phenotype
linking underlying genetic variation with higher order pheno-
types observed at the cellular, organ or organism level. Such
intermediate phenotypes are particularly important for
efforts to understand the genetic basis of heritable human
neurobiological traits; the etiological complexity of such
traits has continued to frustrate genetic mapping efforts.
The use of gene expression profiles as intermediate pheno-
types has been motivated by the demonstration that transcript
levels from healthy human subjects, as measured in peripheral
blood mononuclear cells and derivative lymphoblastic cell
lines, are highly heritable traits which are usually stable over
To whom correspondence should be addressed at: UCLA Center for Neurobehavioral Genetics, Gonda Center, Room 3506, 695 Charles E. Young
Drive South, PO Box 951761, Los Angeles, CA 90095, USA. Tel: þ1 3107949571; Fax: þ1 3107949613; Email: nfreimer@mednet.ucla.edu
# The Author 2009. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Human Molecular Genetics, 2009, Vol. 18, No. 22 4415–4427
doi:10.1093/hmg/ddp397
Advance Access published on August 19, 2009
time (1–3). Numerous expression Quantitative Trait Loci
(eQTL) involved in natural inter-individual differences in
regulation of gene activity have been detected in blood cells
(4). Identification of trans-regulatory elements controlling
gene expression at different genomic locations and cis-
regulatory elements involved in local expression regulation
have provided the basis for better understanding transcrip-
tional regulatory processes.
Inter-individual variation in cortical gene expression has
been correlated with genome-wide genotypic variation (5). It
is, however, extremely difficult to assemble sufficiently large
samples of human brains to enable well-powered eQTL
mapping studies relevant to brain and behavioral phenotypes.
Such mapping studies, therefore, depend on a systematic strat-
egy for identifying brain-related transcripts that demonstrate
high inter-individual variability and that can be assessed in
readily accessible surrogate tissues. The accessibility of
blood makes it an attractive substitute for brain tissues, but
there is so far little direct evidence for its suitability for this
purpose.
Studies of different types of acute brain injury in rodents
have revealed overlapping gene expression profiles between
brain and blood (6–8). In humans, the utility of blood as a sur-
rogate for brain tissues has been supported mainly through
indirect investigations of expression profiles in relation to
specific neurological and psychiatric diseases (9–13). Such
studies have shown that, in both brain and blood samples,
expression patterns distinguish between samples drawn from
patients or control individuals.
Much less data are available from direct comparisons of
brain and blood expression patterns. One such study (14)
observed a correlation of about 0.5 in transcript levels
among all genome-wide transcripts expressed both in brain
and whole blood, including substantial correlations in tran-
scripts representing putative candidate genes for schizo-
phrenia. Further studies are needed to extend our database of
transcripts whose levels of expression are reliably concordant
between brain and blood. Such information is necessary for
the development of large scale studies aiming to map eQTL
that are relevant to our understanding of brain and behavioral
traits.
We describe here the results of direct comparisons of tran-
script levels between blood and brain samples in a set of
related, apparently healthy vervet monkeys, members of an
extended pedigree [the Vervet Research Colony (VRC)] in a
species (Chlorocebus aethiops) widely employed as a model
system in biomedical research. The recent divergence time
(23–25 million years) between hominoids and Old World
monkeys (15) is reflected in extensive similarities in neuro-
physiology and neuroanatomy, and in conservation of
genomic sequences (94% sequence identity between
humans and vervets) that enables the use of human-specific
tools to assess gene expression in Old World monkeys.
The key factors in performing reliable comparisons between
blood and brain tissue gene expression are the collection of
samples under uniform, well-controlled conditions, the use
of a stringent protocol of tissue dissection and sample preser-
vation, and the use of high-quality RNA for gene expression
studies. Each of these goals is more readily achievable in a
non-human primate model than in human studies. Large-scale
gene expression profiling of human brain samples is limited by
the frequently poor quality of preserved material, and incon-
sistencies between specimens in term of tissue dissection
and preservation, factors which may have contributed to
inconsistent or discrepant results in efforts to replicate gene
expression profiling studies of neuropsychiatric phenotypes
(9,16–18). Additionally, environmental variables, such as
medication use, that may substantially influence gene
expression—are much more difficult to control for in investi-
gations of humans compared with non-human primates.
Our study has taken advantage of several features of the
VRC, to maximize the reliability of expression comparisons
between brain and blood, and to use the information from
such comparisons to design well-powered eQTL mapping
studies. We were able to obtain replicate measurements of
blood expression from several monkeys, and then to collect
from the same monkeys, multiple tissues, including brain
samples, under highly controlled conditions. The colony man-
agement practices minimize environmental variability
between the monkeys. These features enabled us to (i) charac-
terize the extent to which inter-individual variation in brain
gene expression—of transcripts selected using stringent cri-
teria—is reflected in peripheral blood and (ii) to hypothesize
that such variation largely reflects genetic variation. Using
such a stringent approach, we identify an initial set of tran-
scripts whose expression levels show low intra-individual vari-
ation and large inter-individual variation and are sufficiently
heritable to make them candidate expression phenotypes for
eQTL mapping.
RESULTS
We determined gene expression profiles across nine tissues—
eight brain regions [cerebellar vermis, pulvinar, head of
caudate, hippocampus, occipital pole, orbital frontal cortex,
frontal pole, dorsolateral prefrontal cortex (DLPFC)] and per-
ipheral blood—in 12 male vervets. Having transcript measures
from different tissues from the same individuals allowed us to
evaluate, for each transcript, sources of transcript level vari-
ation within and between individuals (Fig. 1). We further
focused on two classes of transcripts characterized by high
variation of expression across brain regions or high variation
between individuals. High spatial and temporal inter-
individual variation determined, respectively, between brain
tissues and blood and between independent blood samplings,
allowed us to investigate heritable brain gene expression
traits in peripheral blood. The brain and blood gene expression
data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus (19) and are accessible
through GEO Series accession number GSE15301 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15301).
To evaluate the impact of probe-target sequence incompat-
ibility in our data set, we compared the number of probes
widely detected in vervet brain tissues (at least 80% of
tissues) and in 193 human cortical samples analyzed by
Myers et al. (5), using 6791 probes that are in common
between the two data sets. At this threshold, 2410 probes
were detected in vervet brain and 4622 probes were detected
in human cortex. There was considerable overlap in the
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probes detected by both studies. In spite of human–vervet
sequence differences, 46% (2128/4622) of the probes detected
in human cortex were also detected in vervet brain, whereas
88% (2128/2410) of the probes detected in vervet brain were
detected also in human cortex, showing that human–vervet
sequence differences do not prevent reliable detection of a
substantial fraction of the brain transcripts.
Transcripts differentially detected between brain tissues
We used the detection status of all 22 184 probes represented
on the Illumina HumanRef-8 version 2 chip across the tissues
sampled in tissue set one to determine relationships in gene
expression between eight brain regions. Distances between
tissues were estimated on the basis of the probes that
showed the most striking differences in terms of number of
shared detections. Most such probes were either detected in
only one tissue or detected in all or most brain tissues. Simi-
larities between all possible pairs of tested tissues are illus-
trated by a heat map (Fig. 2A). Cortical tissues generally
show the greatest similarity within this sample set, but three
genes (KREMEN1, MED13L and ZMYM6) differentiate
orbital frontal cortex from frontal pole and one gene (POLE)
differentiates DLPFC and frontal pole. As reflected in a corre-
sponding dendrogram showing relations between all brain
tissues (Fig. 2B), neocortical regions cluster close to hippo-
campus and are more distantly linked to caudate and pulvinar
tissues, with respect to the number of detected samples. Cer-
ebellar vermis and pulvinar tissues are more distant from
other brain tissues in terms of the number of differentially
detected transcripts on the dendrogram.
When tissues are ranked according to the number of region
specific detections (Table 1), cerebellar vermis is first, fol-
lowed by head of the caudate. Cerebellar vermis shows a
tissue-specific presence of 38 transcripts and absence of
54 transcripts. Transcripts with decreased detection in this
tissue are significantly enriched for genes associated with
developmental processes and coding calcium binding proteins.
In the head of the caudate, 22 transcripts are preferentially
detected. Of these transcripts, 18 have a decreased number
of detections and are enriched for genes associated with neur-
onal activities (2.97E204). Additionally, we grouped together
three frontal regions clustering on the bottom of the tissue
dendrogram—frontal pole, DLPFC and orbital frontal
cortex—and compared them against all other brain tissues,
identifying two transcripts (GPR120 and RASGRF2) as
specifically expressed in these frontal regions.
Ubiquitously detected transcripts differentially expressed
between blood and brain
We focused on transcripts that are ubiquitously detected across
tissues and individuals, as these transcripts provide a means to
investigate brain-related biology using peripheral blood
samples. Of the 22 184 probes on the array, we identified
2481 probes—representing 2430 genes—for which expression
was detected in all 12 individuals in all eight brain regions and
in blood (Supplementary Material, Table S1). The regional
mean expression levels of these ubiquitously expressed 2430
genes were examined in all pairwise comparisons of brain
tissues, and the number of differentially expressed probes
used as a distance metric in a hierarchical clustering analysis
(Supplementary Material, Fig. S2). The relations between
tested tissues based on the number of ubiquitously detected
transcripts with differential expression levels are mostly con-
cordant with relationships determined based on differentially
detected transcripts (previous section) and with relationships
known from human studies (20). The only exception to this
observation is the clustering together of occipital pole and pul-
vinar patterns, while hippocampus unexpectedly localizes
closer to frontal cortex than does occipital cortex (Supplemen-
tary Material, Fig. S2B). Unlike the tissue grouping based on
extreme differences in detection count, this tissue clustering is
based on a group of ubiquitously detected transcripts that is
clearly depleted of transcripts showing the most extreme
differences in expression between tissues, such as those
whose expression is restricted to a specific tissue.
Figure 1. Components of transcript level variation. Observation of transcript levels across different tissues and individuals allows analysis of variation of tran-
script levels from the perspective of its two components: inter-individual variation (green) and intra-individual or between tissue (red) variation. Transcripts
characterized by much higher intra-individual than inter-individual variation provide insight into the functional relationships between different tissues and
may highlight functions attributable to specific tissues. Transcripts characterized by much higher inter-individual than intra-individual variation are of interest
as candidates for mapping brain eQTL using blood as a surrogate tissue. Red boxes on the right represent the probe filtering steps leading to selecting transcripts
for eQTL mapping characterized by high spatial and temporal inter-individual variation.
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Exclusion of the tissue-specific transcripts generates unex-
pected topography in the tissue dendrogram, possibly indicat-
ing that these transcripts determine important regional features
to a greater extent than ubiquitously expressed transcripts.
Nevertheless, the ubiquitously expressed transcripts still may
suggest important aspects of the biology of different brain
regions; as many as 1474 ubiquitously expressed genes show
increased or decreased expression levels in specific brain
regions, based on pairwise comparisons of mean expression
values between tissues (Supplementary Material, Fig. S2A).
Consistent with the suggestion from the detection based
distance measure, the frontal cortical region shows smaller
inter-tissue differences than other tissues tested. Additionally,
a differential mean probe signal was observed for 90 probes
between DLPFC and frontal pole, 92 probes between
DLPFC and orbital frontal cortex, and 215 probes between
frontal pole and orbital frontal cortex.
Among the 2430 ubiquitously expressed genes, we ident-
ified genes showing region—specific differential expression,
and we determined functional categories that were under—
and over-represented among these genes (Supplementary
Material, Table S2). Consistent with the results of the differen-
tial detection measures, cerebellar vermis, and head of caudate
show the largest differences from other tissues in the number
of genes showing differential mean expression levels (790 and
383, respectively). Genes differentially expressed between
cerebellar vermis and all other tissues are associated with
two interrelated functions, metabolic processes of nucleic
acids and mRNA transcription. These two biological processes
are significantly over-represented (6.4E211, 7.06E203,
respectively) among 533 up-regulated genes and under-
represented (1.00E205, 3.84E202) among 257 down-
regulated genes, which may indicate distinctive transcriptional
regulation mechanisms acting in this brain region. In head of
caudate, a group of 244 up-regulated genes includes structural
proteins of small and large units of cytoplasmatic (21) and
mitochondrial (5) ribosomes. As a result, among the genes pre-
ferentially expressed in this tissue, molecular function of ribo-
somal proteins is significantly over-represented (2.16E204),
suggesting that specific protein synthesis mechanisms and
regulation may be characteristic of this brain region. Among
genes down-regulated (139) in head of caudate, there is an
over-representation of kinases (4.05E202).
Genes ubiquitously detected in brain and blood tissues
Among 2481 transcripts that are ubiquitously detected in brain
and blood tissues, 2430 also show differential expression
between tissues. This group of 2430 transcripts does not
include transcripts showing the most extreme differences in
cross-tissue expression patterns, such as transcripts expressed
exclusively on a single region. A large number of such differ-
entially expressed transcripts (1474) are still widely detected
across brain and blood tissues. This set of genes is clearly
depleted of genes related to many brain-specific functions
including signal transduction or neurogenesis, while it is
enriched (with P-values less than 0.05) in genes related to
the ubiquitin proteasome system, Parkinson disease (e.g.
SNCA, synuclein-alpha) and Ras pathways as well as genes
involved in the various biological processes and molecular
functions related to mRNA and protein metabolism (Sup-
plementary Material, Table S3).
Over representation of genes involved in basic biological
processes is consistent with a high representation of house-
keeping (HK) genes which, by definition, are widely expressed
in numerous human tissues and are involved in maintenance of
basal cellular functions. More than 44% of recognized HK
genes (255/575) are ubiquitously detected in vervet brain
and blood tissues. Among these, HK genes are genes widely
used in quantitative RT–PCR as control genes whose
expression is assumed to be constant among samples
(21,22). It is therefore noteworthy that from the genes utilized
as endogenous controls, ARHGDIA, POLR2A and RPS18
Figure 2. Gene expression differences between brain tissues. Pairwise com-
parison between all eight brain regions is presented on a heat map (A) con-
structed based on differentially detected transcript. Corresponding
hierarchical clustering of tissues is presented on a dendrogram (B). Tissue
labeling: CV—cerebellar vermis, Pu—pulvinar, Hi—hippocampus, OP—
orbital pole, FP—frontal pole, DLPFC—dorsolateral prefrontal cortex,
OFC—orbital frontal cortex.
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showed differential regional expression and therefore do not
suit the purpose of tissue-to-tissue normalization. As expected,
this group of HK genes is enriched for genes involved in main-
tenance of constitutive functions such as protein and mRNA
metabolism, ribosomal activity, energy release and cyto-
skeletal regulation (Supplementary Material, Table S4).
Here among the genes broadly expressed in brain and blood
tissues, we detected a considerable number of ubiquitous tran-
scripts that were previously reported as stable across tissues
HK genes. Analysis of blood and high-quality brain tissues
from precisely dissected regions revealed that levels of
almost all these ubiquitous transcripts vary between at least
one pair of tested tissues in the current study.
Variation of transcript profiles in brain and blood tissues
To identify probes showing correlated expression profiles in
brain and blood tissues, we estimated, for each brain region, the
Spearman rank correlation (SRC) between the paired brain and
blood expression measures. Additionally, to identify probes
with greater inter-individual variation than intra-individual vari-
ation, we used a variance components approach to estimate the
percent variation (PV) attributable to the inter-individual com-
ponent and within monkey component (between tissues). Both
measures (SRC and PV) for the whole brain and blood data set
are available on the Integrated Vervet Monkey Genomics
website: http://genomequebec.mcgill.ca/compgen/submit_db/
vervet_web,which enables searches for similarities of expression
profiles between eight brain regions and blood for specific genes.
Examples of brain–blood expression patterns are shown in
SupplementaryMaterial, Figure S3, for highly correlated profiles
(left column), moderately correlated profiles (middle column)
and poorly correlated profiles (right column).
Among the 2481widely detected probes, 825 showPV.0.55
and SRC .0.55. For the 2481 ubiquitously detected probes, the
number of brain regionswith PV.0.55 orwith SRC.0.55was
skewed in favor of excluding a majority of probes and varied
from zero brain regions (PV: n ¼ 1329, SRC: n ¼ 1574) to all
eight brain regions (PV: n ¼ 52; SRC: n ¼ 28). The probes
exceeding these PV and SRC thresholds for each brain region
are shown in Supplementary Material, Table S5. Correlated
expression patterns and inter-individual variation (according
to the above criteria) in all eight brain regions were attributable
to 23 genes: SPOCK2, HSBP1,CLN3, CIRBP, ANXA11, PNKP,
CCT2, RPS20, GGA2, SCO1, CCDC115, DDOST, DUSP11,
MRPL51, DMTF1, RPL31, RPL35A, LARP5, SS18L2,
TUBA1B, C9orf114, SRF, MRPS17. Even though these genes
displayed correlated patterns across all brain tissues, ten of
them showed regionally increased or decreased expression
levels, for example, three-ribosomal genes RPS20, MRPL51
and RPL35A are up-regulated in the head of the caudate in com-
parison to all other brain tissues. Supplementary Material,
Table 1. Region-specific transcripts identified based on differential detection
Brain region Genes with increased regional number of detections Genes with decreased regional number of detections
Cerebellar
vermis
38: ARHGEF10L, BARHL1, C12orf28, CD2AP, CDH15, CDH23,
CERKL, CLDN3, CNNM4, CTRL, DNAJC12, E2F7, EBF3, ECM2,
EN2, ERN1, FAT2, GABRA6, ITGA11, KCND1, KIAA0889,
KRT72, MRGPRF, MRPL43, NPFF, NRK, NUPR1, ONECUT1,
P2RX1, PCP2, PGAM2, PLD5, RAB37, RAB4A, RPS6KA1,
TFAP2B, THRSP, ZNF662
BPa: "developmental processes 1.63E202
MFa: "select calcium binding protein 3.57E202
54: ADAMTS8, ALDH4A1, BAI1, BCL11A, C1orf165, C1QL1,
C22orf25, C3orf54, C6orf117, C9orf117, CDH8, CHSY-2, CPNE4,
CRABP1, CSNK1G1, CUGBP2, CXCL14, DDN, DUSP15,
EFEMP1, EGFL7, ERF, FBLN1, FLJ33590, FZD8, GPR26,
KCNB2, KCNQ3, LHX2, LOC730413, LRRC7, LY6H, MAFB,
NELF, NELL1, NR2E1, OAF, P11, PCDH10, PDE2A, PNKD,
PRG2, PTGS1, RAB11FIP4, RAI14, RASAL2, RASD2, RPE65,
SAMD5, SDCBP2, SH3PX3, ST3GAL1, TNNI3, TSHZ2
Pulvinar 15: ARHGAP24, C1orf76, CYP26A1, FLJ45455, IGSF1, LHX9,
NKD1, PLAC2, PNOC, SEMA4G, SLC25A24, TCF7L2,
TMEM41A, TSPAN2, VEGFC
8: ADPRHL1, ARHGAP26, BAIAP2, C20orf103, CCKBR, RYR2,
SLC16A11, TMOD1
Head of
caudate
22: AMBN, CKM, DRD1, DRD2, DRD2, ERAF, GPR52, GPR88,
HCRT, ISL1, MYH3, NPPB, PTPN7, RGS9, RXRG, SFN, TMC8,
TMEM16B, TMEM45A, UPB1, UPP2, VTCN1
BPa: "neuronal activities 2.97E204
18: ACVR2A, BDNF, CLIP1, CYP26B1, ELAVL2, FAM80A, GALNT9,
GEFT, GK, GRM2, LIN7A, MEX3B, MKX, NTNG1, PTPN3,
SLC17A6, SNCB, TBKBP1
Hippocampus 2: LXN, NRG1
Occipital pole 2: LAG3, OSTN
Frontal
regionsb
2: GPR120, RASGRF2 1: CA12
The comparisons were done on a pairwise basis between tissues, and a probe was differentially detected in two tissues if in one tissue it was detected in less than
two subjects and in the other tissue it was detected in nine or more subjects. This table is based on all 22 184 transcripts. Underlined—transcripts exclusively
detected in all samples from a given brain region while was absent in all samples form other brain regions or transcripts absent in all samples from a given tissue
while detected in all samples from other brain regions.
aStatistically significant functional associations of Panther ontology terms with listed gene transcripts; BP, biological process; MF, molecular function.
bOrbital frontal cortex, DLPFC and frontal pole versus all other tissues.
Human Molecular Genetics, 2009, Vol. 18, No. 22 4419
Table S6 shows the number of probes that met PV and SRC cri-
teria for comparison between blood and each brain region. Both
methods consistently identified hippocampus as the brain region
most dissimilar to peripheral bloodwith regard to transcriptional
profiles, but did not show considerable variation among other
brain tissues. Probes that have passed the PV and SRC
thresholds, for at least one brain region, are probes that show
similar profiles in brain and blood expression and have more
inter-monkey variation than intra-monkey variation. Therefore,
these selected probes can be further studied in blood samples to
identify brain gene expression traits.
For investigating specific regional brain functions, genes
expressed only in one or a few brain regions only are of inter-
est. Such regional specificity, however, is likely to predict lack
of expression of transcripts in peripheral tissues and therefore
the impossibility of using correlated brain and blood
expression patterns to guide studies of such transcripts in per-
ipheral blood. We verified that only three transcripts in our
data set (LHX1, PPP1R1B and RGS9) meet both tissue-
specific detection and brain–blood correlation criteria.
Variation of transcript profiles in peripheral blood
in replicate samples
To assess the reproducibility of gene expression profiling,
which could be affected by either technical variation or tran-
script level stability over time, we used expression data set
two, derived from 18 monkeys each sampled twice for blood.
From the initial list of 22 184 probes, we identified 1880
probes that were detected in peripheral blood in all 36 replicate
samples from 18 monkeys. We required detection in all repli-
cates in order to identify the most reliable transcripts for
future eQTL mapping in blood samples. The group of 1839
genes represented by these1880 probes is greatly enriched for
genes involved in protein and mRNA metabolism and various
signaling pathways, as well as pathways characteristic of per-
ipheral blood such as lymphocyte activation and inflammation
(Supplementary Material, Table S7). Among the most
overrepresented biological processes in this set of genes are
those implicated in oxidative phosphorylation, apoptosis,
immunity and defense, and cell cycle, structure and motility.
Nucleic acid binding, and ribosomal and cytoskeletal functions
are the molecular functions most enriched among these genes.
To determine the biological reproducibility over time of the
gene expression profiles in these 1880 probes, we assessed the
within monkey versus between monkey (between duplicate
samplings) variance, including sex as a fixed effect in the
model. Examples of the similarity in expression signal
between replicate samples is shown in Supplementary Material,
Figure S4, for highly correlated replicates (left column), moder-
ately correlated replicates (middle column) and poorly corre-
lated replicates (right column). There were significant
differences (at the 0.05 level, uncorrected for multiple testing)
between males and females in blood expression data for 238
of the 1880 probes that passed the detection threshold.
For each of the 18 vervets with duplicate blood expression
measures, correlation of duplicate measures across all probes
was at least 0.9 (range across the 18 vervets was 0.89–
0.99). To identify transcripts with stable levels in blood but
differentially expressed between monkeys, we focused on
transcripts which had more variation between monkey than
within monkey (temporal transcript variation in blood and
technical reproducibility) as defined by the percent of total
variance attributable to the within monkey component
PV.55%. Among the 1880 probes that passed the detection
threshold in peripheral blood replicate samples, there were
134 probes (representing 133 genes) with PV.0.55, indicat-
ing that for these probes the majority of the total variation
in probe signal was between monkey rather than within
monkey (between replicates over time). Both high inter-
individual variation and intra-individual reproducibility make
these selected genes suitable candidates for genetic mapping
of their eQTL.
Selection of candidate transcripts for eQTL mapping
We merged results from data sets one and two to select
expression traits for future eQTL mapping. We examined the
2481 probes that passed detection thresholds in brain and
blood expression data set one to identify probes that passed
PV and SRC thresholds for both brain–blood similarity (825)
and the PV threshold for biological reproducibility (Fig. 3A)
from data set two (130). We identified 53 of 2491 probes that
met both these criteria, i.e. having correlated expression profiles
in brain and blood (for at least one brain region) and showing
more inter-individual variation than intra-individual (between
tissues) variation. Next, we limited the list of probes to the
probes that meet the detection threshold (36 measurements)
for the biological reproducibility data set (Fig. 3B). The
reduced subset of 32 probes passing all variation, reproducibil-
ity and detection thresholds is presented in Table 2.
Significant correlation and PV of the TUBA1B transcript
and also PV of additional transcripts (BAT1, C19orf62, EIF1
and SUV420H1) was observed between all brain regions and
blood, suggesting a common regulatory mechanism acting
across brain tissues. Region-specific correlation of brain
expression with blood was observed in caudate (EIF1), cer-
ebellar vermis (SMOX and TSPAN14), DLPFC (SLC25A23),
frontal pole (RAB5A), hippocampus (STOM) and orbital
frontal cortex (ERAL1 and TFE3); no such correlation was
observed specifically for occipital pole and pulvinar.
Using transcript levels measured in the peripheral blood of
347 individuals (tissue set three) from the extended vervet pedi-
gree with known and genetically confirmed structure, we esti-
mated the heritability of the 32 selected transcripts (Fig. 3B,
Table 2). Twenty-nine of these expression traits showed herit-
ability at a significance level less than 0.05 and 25 transcripts
showed heritability at P , 0.001; 62.5% of these traits dis-
played heritability estimates of 0.4. The generally high herit-
ability of these transcripts suggests that selecting transcripts
whose inter-individual variation in transcript levels is greater
than their intra-individual variation, identifies transcripts
whose regulation has a strong genetic component. Evidence
consistent with this hypothesis is provided by much lower esti-
mates of heritability in a comparison set of 32 transcripts chosen
randomly from the data set (data not shown).
Polymorphisms located within a probe sequence may cause
differential hybridization which mimics differential expression
results and lead to inaccurate estimates of the heritability of
levels of particular transcripts. To assess the effects of such
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polymorphisms on our results, we sequenced probes for
16 transcripts showing significant heritability in the vervet
monkey pedigree. Ten of these probes were monomorphic.
For the six probes in which we detected SNPs (TUBA1B,
TMED3, BAT1, CDKN1A, C19orf62 and SMOX), we compared
expression level measures between different SNP genotype
classes to observe possible correlations between signal intensity
and genotype. Four of these six probes showed marked corre-
lation between signal intensity and genotype, raising the possi-
bility that probe hybridization properties rather than differential
gene regulation are responsible for observed inter-individual
variation in these transcripts. A probe for the SMOX transcript
did not show such signal intensity–genotype correlation, most
likely due to the low frequency of the minor allele. The probe
for the CDKN1A transcript showed consistent differences
between genotypes in seven tested tissues but not in hippo-
campus and pulvinar. This observation suggests that the
CDKN1A probe is sensitive to transcript level, but confirmation
of this interpretation will require use of an alternative gene
expression assay such as quantitative real-time PCR.
Fourteen of the heritable transcripts showed differential
expression levels across brain regions. This group includes
transcripts specifically elevated in cerebellar vermis (5),
head of caudate (3) and hippocampus (1). It will be of interest
to examine further the genetic determinants of regional gene
expression that may be involved in specific tissue functions.
DISCUSSION
We are developing genome-wide gene expression resources
for the vervet that permit investigation of variation between
different tissues within an individual or between individuals.
Genome-wide gene expression studies may provide compre-
hensive insight into gene activities and biological pathways
differing between various tissues and individuals. Brain
regional differences in gene expression levels relate to specific
functions of brain tissues including disease symptoms distinc-
tively affecting specific brain regions, while variation in brain
gene expression profiles among individuals indicates possible
genetic factors regulating gene transcript levels. Our research
addressed both kinds of gene expression variation—between
brain regions and between individuals—by expression profil-
ing in brain tissues derived from eight brain regions and
blood from 12 vervet monkeys.
Regional brain expression profiles in vervet
Weemployed the vervetmonkey as a non-human primatemodel
to assure precisely dissected high-quality brain tissues, which
are difficult to obtain from human subjects. Gene expression
profiles from distinct vervet brain regions are generally compar-
able to profiles of equivalent human brain regions, as indicated
by the similarity of the hierarchical structure of tissue dendro-
grams (20). On the basis the observed overall conservation of
gene expression profiles between vervet and human brain
regions, we expect that identification of genes that are preferen-
tially expressed or that show exclusive expression in specific
vervet brain regions may provide a means to identify genes
with region-specific functions in humans. Several of these
genes are already known to be involved in region-specific func-
tions, for example the caudate-specific transcript RGS9, which
is inversely correlated with striatal dopamine metabolism (23).
Candidates for mapping eQTL
The primary focus of our study was to identify correlated
brain and peripheral blood transcriptional profiles that
could be reproducibly measured over time. We selected
Figure 3. Selection of candidate transcripts for mapping brain eQTL in peripheral blood. The diagram represents the set of probes in the brain–blood gene
expression comparison that passed the 55% threshold for PV (PV BB) and the 0.55 threshold for the SRC for any of the brain regions, and the set of probes
that passed the 55% threshold for PV in blood replicate samples PV Replic. (A) All 2481 probes that passed detection thresholds in brain and blood expression
data. Considering just the brain–blood similarity analysis, 825 probes (33%) had both PV. 0.55 and SRC. 0.55. (B) The subset of 1515 probes that also
passed detection thresholds in the replicate blood sample data set. Although the absolute number of probes is reduced according to detection criteria, the dis-
tribution of number of probes to pass PV and SRC thresholds in both brain–blood similarity and the PV threshold for biological reproducibility is very similar;
for example 474 probes (31%) had both PV. 0.55 and SRC. 0.55.
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stable blood biomarkers of brain gene expression that may
warrant further investigation of expression eQTL differen-
tially regulating transcript levels in the brain across individ-
uals. Our approach to select promising candidates for
mapping brain eQTL using blood as a surrogate tissue
included very restrictive criteria for probe filtering. We
focused on transcripts with both ubiquitous tissues expression
and with much higher inter-individual than intra-individual
variation, which resulted in selecting a relatively small
number of candidate transcripts (32). However, both the
high proportion of heritable transcripts in this selected set
(90%) and their high estimated heritabilities demonstrate
the utility of this approach for identifying transcripts whose
variation has a strong genetic component. These heritable
expression phenotypes can be genetically mapped using the
VRC pedigree, which has proven to be an efficient tool for
linkage studies (24,25). It is hypothesized that heritable vari-
ations in transcript levels are more directly related to under-
lying genetic variation than many other nervous system traits,
and therefore these molecular phenotypes are attractive can-
didates for genetic mapping. Indeed several studies using
recombinant inbred mouse strains have clearly demonstrated
the utility of eQTL studies focused on brain tissues for
mapping of complex traits related to these tissue (27–30).
We consider that the 32 transcripts highlighted by this study
provide an initial set of candidate transcripts for brain-related
Table 2. Thirty-two candidate genes for mapping brain eQTL in peripheral blood
Probe
ILMN_
Gene symbol Entrez Gene name Brain
expressiona
H2r
P-value
H2r Covariateb Relation to disease
1657857c TMEM14C Transmembrane protein 14C 7.32E222 0.71 B
1764813c B3GALTL Beta 1,3-galactosyltransferase-like CV# 6.98E214 0.78 SAB Peters-plus syndrome
(MIM#261540)
1669878 GUSB Glucuronidase, beta 1.01E213 0.64 B Mucopolysaccharidosis VII
(MIM #253220)
1719316d TMED3 Transmembrane emp24 protein transport
domain containing 3
2.35E213 0.64 SB
1686626d BAT1 HLA-B associated transcript 1 CV" 4.11E213 0.60 AB Asthma, myocardial
infarctione
1812325 TMEM111 Transmembrane protein 111 CV# 9.48E213 0.75 B
1800261d TUBA1B Tubulin, alpha 1b 8.23E211 0.65 SAB
1718831 TMEM57 Transmembrane protein 57 CV" 1.19E210 0.58 SAB
1768031c DEDD2 Death effector domain containing 2 CV"OP # 7.92E209 0.56 SAB
1784602d CDKN1A Cyclin-dependent kinase inhibitor 1A 1.01E208 0.47 B Cancere
1692026c SUV420H1 Suppressor of variegation 4-20 homolog 1 CV" 8.71E208 0.43 None
1708516c PRTFDC1 Phosphoribosyl transferase domain containing
1
1.02E207 0.44 SAB
1806937d C19orf62 Chromosome 19 open reading frame 62 1.92E207 0.51 SAB
1679949 SLC25A23 Solute carrier family 25 (mitochondrial carrier;
phosphate carrier), member 23
Ch" 4.31E207 0.43 SA
1686099 ZFYVE1 Zinc finger, FYVE domain containing 1 6.54E207 0.43 B
1718706 ERAL1 Era G-protein-like 1 6.93E207 0.47 B
1726456 SLC3A2 Solute carrier family 3 (activators of dibasic
and neutral amino acid transport), member 2
CV# 9.37E207 0.46 AB
1766657c STOM Stomatin CV# 9.41E207 0.45 B
1761176 GRIPAP1 GRIP1 associated protein 1 5.65E206 0.34 B
1775380d SMOX Spermine oxidase 2.97E205 0.41 SB
1785060 TSPAN14 Tetraspanin 14 7.95E205 0.41 SA
1764826c TFE3 Transcription factor binding to IGHM
enhancer 3
1.81E204 0.28 AB Renal carcinoma
(MIM#605074)
1808875 RAB5A RAB5A, member RAS oncogene family CV"Ch# 2.29E204 0.35 B
1712312c RAB11A RAB11A, member RAS oncogene family H" 2.52E204 0.34 AB
1779735c LOC389541 Chromosome 7 open reading frame 59 6.56E204 0.31 SB
1739641c MTMR3 Myotubularin related protein 3 CV# 3.17E203 0.28 B
1737074 LOC440589 Hypothetical LOC440589 CV# 1.24E202 0.22 B
Ch"
1662905 NME1-NME2 NME1–NME2 read-through transcript CV#Ch" 2.28E202 0.20 B Cancere
1716260 HSPA8 Heat shock 70 kDa protein 8 3.86E202 0.16 SB Kidney failuree
1803846 EIF1 Eukaryotic translation initiation factor 1 7.51E202 0.17 SB
1682299 NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex, 11
9.05E202 0.14 SAB
1695420 CLTA Clathrin, light chain (Lca) Ch# 3.68E201 0.03 B
aGenes "up- or #down-regulated in a single-brain region compared with all other regions, CV, cerebellar vermis; Ch, head of caudate; OP, occipital pole; H,
hippocampus.
bImportant covariates: A, age; S, sex; B, batch.
cProbe region uninterrupted by SNPs in vervet.
dProbe region containing SNPs in vervet.
eGenetic Association Database (GAD).
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eQTLmapping using peripheral blood measurements. It is likely
that further investigations—using larger samples and more
powerful technologies for measuring gene expression—will
identify a much larger set of transcripts suitable for eQTL ana-
lyses. We anticipate, for example, that such investigations may
incorporate a substantial number of transcripts for which we
found evidence suggestive of brain–blood correlation in
expression levels but that we now exclude due to the stringency
of our selection criteria. We further emphasize that the use of
such rigorous criteria currently precludes us from drawing infer-
ences regarding the overall degree of such brain–blood corre-
lations among the transcripts assessed in this study.
Utility of vervet as a translational model
By applying rigorous inclusion criteria, we identified transcripts
whose stable profiles in blood also reflect their profiles in brain.
These transcripts therefore provide easily accessible biomarkers
of brain gene expression variation. The substantial known simi-
larities between human and vervet in regional brain expression
suggest that the transcripts identified here as stably correlated
between brain and blood in vervet may be similarly informative
in human studies that assay inter-individual variation of
expression in peripheral blood. Information from this type of
investigation of vervets or other non-human primates could be
very valuable, given that reliable brain–blood gene expression
comparisons in human subjects are limited by the availability
and quality of matched blood and brain tissues.
Studies of expression quantitative traits using brain–blood
expression profile correlation in the vervet model also have
wider implications for understanding complex human neurobe-
havioral traits. Several quantitative variables that are relevant to
such traits are the focus of active genetic investigation in the
vervet, including variation in neuroanatomic features (26),
neurochemistry (24) and disease-related behaviors such as
impulsivity (27). The opportunity to investigate these
phenotypes—in conjunction with gene expression profiling—
longitudinally is another important advantage of such a non-
human primate model. The availability of such gene expression
profiles may greatly facilitate the identification of the genetic
variants underlying variation in such traits.
Technical issues
Two types of technical issues influence the interpretation of our
results; the first issue concerns the complexity of the tissues ana-
lyzed and the second issue concerns the effect of possible incom-
patibilities between microarray probe sequences and the
transcripts under investigation. Tissue samples derived fromana-
tomically different brain regions, even when carefully dissected,
show substantial complexity at a cellular level (28). The diversity
of cell types in the brain tissues that we have investigated may
influence the results presented here regarding gene expression
across brain regions and peripheral blood. Different brain
regions show different levels of cellular complexity (29). Such
cellular heterogeneity may particularly strongly affect low abun-
dance transcripts which are known to be important contributors
to the specificity of brain-related functions (29). An alternative
approach to studying overall regional brain expression is high
resolution analysis of specific cells isolated from tissues using
laser capture microdissection (30), although this approach is
not currently practical for large-scale studies.
The sequence divergences between humans and vervets
result in imperfect hybridization which may clearly lower
transcript detection. However, our observation that most of
the probes that were widely detected in vervet samples were
also detected in a similar proportion of human brain
samples, demonstrates the overall expression similarities
between human and vervet brain and indicates that such false-
negative results are unlikely to be a substantial issue in inter-
preting the findings reported here.
False-positive results may result from genetic variants in
probe interaction sites, causing differential probe hybridiz-
ation between individuals. Although commercial microarrays
are designed to minimize the inclusion of known common
sequence variants in such sites, several studies have shown
that a substantial fraction of probes contain at least one SNP
(31,32). In our study, it is not currently possible to estimate,
on a genome-wide basis, the degree of vervet genetic variation
in the sequences corresponding to human probes. Interpret-
ation of gene expression profiling in the vervet will be
enhanced in the near future using data generated by the
Vervet Genome Sequencing Project (VGSP), which has been
initiated recently. The VGSP is not only determining the
vervet reference genomic sequence, but is also cataloging
common vervet SNPs on a genome-wide basis.
Until such data are available, targeted resequencing is required
to determinewhether vervet genetic variationmaybe influencing
particular expression results.We have shown that themajority of
heritable transcripts that we have suggested as candidates for
eQTL mapping, show true inter-individual variation in
expression rather than hybridization artifacts. Although we
identified genetic variation in more than a third of the probes
thatwe sequenced, it is not evident that this proportion is substan-
tially different than that observed in experiments where the array
and the transcript both represent the same species. Rather, the
potential for false-positive results reflects the intrinsic drawbacks
of array-based approaches for assessing gene expression.
This kind of false-positive effect may be enriched among
transcripts that show correlation between blood and all brain
regions, whereas correlations observed between blood and a
single brain region or only few brain regions are less likely to
reflect the effect of a SNP on probe hybridization affinity.
As in other species, we anticipate that investigation of gene
expression in the vervet will evolve from array-based to more
sensitive and specific sequencing-based approaches. It is likely
that we will be able to detect a much larger number of tran-
scripts for which the pattern of expression in blood and
brain can be correlated, and therefore which will be suitable
candidates for genetic mapping of eQTL relevant to brain.
The high-quality tissue and RNA resource that we have estab-
lished will be extremely valuable for mapping brain
expression traits using blood as a surrogate tissue.
MATERIAL AND METHODS
Subjects and tissue samples
Tissue specimens were collected from vervet monkeys that
were related members of the VRC pedigree. Three tissue
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sets were collected within the VRC. Set one consisted of brain
and blood samples collected from 12 monkeys. Set two
consisted of replicate blood samples collected from
18 monkeys. Set three consisted of blood samples
collected from vervets over 2 years old from the entire
pedigree, n ¼ 347.
Set one sampled for comparison of gene expression between
brain and peripheral blood, was collected from 12 male
vervets, aged 3 years at the time of sample collection. The
average kinship coefficient among the 12 monkeys represented
in tissue set one was 0.025 (min¼0.0035, max¼0.154). These
subjects were euthanized by ketamine (10 mg/kg, intramuscu-
lar), followed by overdose with sodium pentobarbital
(30–60 mg/kg, intravenous). Circulatory perfusion with
cooled isotonic saline was achieved by cardiac cannulation;
after 15 min of perfusion, the calvarium was opened, the
brain was removed and coronally blocked and samples were
microdissected on a thermostatic platform held at 4–68C.
Tissue was collected from eight brain regions: cerebellar
vermis, pulvinar nucleus, head of the caudate, hippocampus,
frontal pole, DLPFC, orbital frontal cortex and occipital
pole. Localization of sampled regions is shown in Supplemen-
tary Material, Figure S1. A sample of 20–180 mg of tissue
from each brain region was collected directly into RNAlater
reagent (Ambion), immediately stabilizing the RNA profiles.
Set two, enabling gene expression analysis of biological
replicate samples, was collected twice, at 20 weeks intervals,
from the peripheral whole blood of 18 VRC animals;
12 males (5.5–7.8 years old, mean 6.4 years old) and six
females (4.7–7.6 years old, mean 6.1 years old). For blood
collection, animals were anesthetized with ketamine HCl
(8–10 mg/kg, intramuscular) and blood was collected via
femoral venipuncture. The average kinship coefficient
among the 18 monkeys sampled twice was 0.026 (min¼0,
max¼0.204).
Set three, enabling estimation of heritability of gene
expression data, was obtained from peripheral blood drawn
from 347 monkeys aged 2 years and older. For blood
samples, 2.5 ml of peripheral blood was drawn from
the femoral vein directly to a PaxGene RNA Blood tube (Pre-
AnalyticX) containing a solution to preserve RNA integrity.
RNA samples
Total RNA from whole blood preserved in PaxGene RNA
Blood tubes (PreAnalyticX) was extracted using PAXgene
Blood RNA Kit (PreAnalyticX). Total RNA from RNAlater-
preserved brain tissues was isolated with PefectPure RNA
Cell and Tissue Kit (5 Prime) using 20–40 mg of brain
tissue homogenized with rotor-stator (Omni International).
Since the most important confounding factor affecting
expression levels is total RNA quality, we evaluated the
total RNA integrity of all of our tissue types (Supplementary
Material, Table S8) using the Agilent 2100 Bioanalyzer with
the RNA 6000 Nano Assay Kit (Agilent Technologies).
Average RNA integrity number (RIN) for eight brain tissue
types ranged from 7.5+ 0.4 for head of caudate to 8.2+ 0.5
for cerebellar vermis (Supplementary Material, Table S8).
All RIN values were greater than 7. Observed RIN values
are generally higher and less variable than those usually
obtained from human post-mortem brain tissues. For
example, Lipska et al. (33) reported RIN for human tissues
of 5.7+ 1.0 (hippocampus) and 6.7+ 1.3 (DLPFC),
whereas we obtained respective RIN values of 7.6+ 0.4 and
7.5+ 0.3 for the same tissue types. For blood samples, our
average RIN was 9.1+ 0.6. Total RNA sample concentrations
were quantified with RiboGreen RNA (Invitrogen).
Microarray measurements
For assessing transcript levels, we used the Illumina
HumanRef-8 v2 chip. This chip provides genome-wide tran-
scriptional coverage of well-characterized genes. Low rep-
resentation of splice isoforms on this chip do not, however,
allow efficient assessment of splicing QTL (sQTL).
This chip uses 22 184 probes representing 18 189 unique
human genes (or 20 424 unique transcripts) from Reference
Sequence database1, Release 17. The Illumina gene expression
platform utilizes long 50-mer gene-specific probes that provide
both good selectivity and sensitivity (34). Although short oligo-
nucleotide probes (32-mers or shorter) are very sensitive to
probe-target mismatches such as these resulting from sequence
variation between individuals, long cDNA probes are less influ-
enced by such mismatches (35–39). We used intermediate size
oligonucleotides expecting that these probes would sufficiently
tolerate sequence incompatibilities between human probe
sequence and vervet target transcripts and be more robust
than shorter probes to possible allelo-specific differences in
hybridization efficiency due to vervet-specific SNP variants
occurring in probe-interaction sites (40).
cDNA was synthesized and in vitro transcribed into biotiny-
lated cRNA using the Illumina Totalprep RNA amplification
kit, following the manufacturer’s instructions (Ambion).
Labeled cRNA was hybridized to the HumanRef-8 version 2
(Illumina) gene expression bead-chip. A gene was called
detectable by BeadStudio when the detection P-value was
less than 0.01. The gene expression module of the BeadStudio
software version 3.1 (Illumina) was used for initial data pro-
cessing and background correction. Lumi software was also
used to perform a variance-stabilizing transformation that
takes advantage of the technical replicates available on
every Illumina microarray (usually over 30 randomly distribu-
ted beads per probe), and subsequently performs robust spline
normalization and quality control of gene expression measures
(41). Expression profiles from all collected samples passed
sample quality checks in Lumi, except for one pulvinar
sample that was excluded from further analysis. Therefore,
the total brain and blood sample set used for subsequent analy-
sis consisted of 12 samples from blood and from all brain
regions except the pulvinar, which was represented by
11 samples in this study.
Probe filtering
For quality control purposes, gene expression data were fil-
tered based on detection scores defined by Illumina (detection
P, 0.01). We used two criteria to select probes for further
analysis: (i) detection in all brain and blood samples from
the 12 animals in the brain and blood data set and (ii) detection
in all 36 samples from the biological replicate blood data set
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(two samples from each of 18 vervets). Although both steps
narrowed down the number of transcripts analyzed to select
candidates for brain eQTL mapping, they permit selection of
transcripts consistently measured across the samples despite
possible sequence incompatibilities in cross species hybridiz-
ations. By applying very stringent detection criteria, we
excluded also many potentially interesting transcripts that
were detected in some but not all brain regions. As such tran-
scripts did not show sufficient correlation between the tissues
of interest and blood, we chose not to examine them further
through pedigree-wide expression profiling in blood.
Variance component and correlation analysis
For each brain region sampled in tissue set one, we used a
mixed model ANOVA and a variance components approach
to compare the blood expression levels to those in each of
the eight brain regions. Each analysis included 12 paired
expression measurements, one from blood and one from a
given brain region, from each animal. The total variation in
expression for any probe can be divided into the between
monkey component and the within monkey (between blood
and brain tissues within the same monkey) component.
Probes where most of the variation is attributable to the
between monkey component show more inter-monkey vari-
ation than intra-monkey variation, and therefore have less
variation between blood and brain tissue than between
monkeys. Prior to performing the variance components analy-
sis, brain and blood measures were standardized to Z-scores
separately for each tissue type by subtracting the mean and
dividing by the standard deviation (both mean and standard
deviation were determined across animals), as overall mean
levels of expression may differ in brain tissues and blood.
We also estimated the SRC between expression levels in
blood and expression levels in each brain region.
Variance components analysis was also used in a similar
manner on the biological replicates data set in tissue set two.
The total variation in expression for any probe can be
divided into the between monkey component and the within
monkey (between replicates from the same monkey) com-
ponent. Probes where most of the variation is attributable to
the between monkey component show more inter-monkey
variation than intra-monkey variation, and therefore have
less variation between replicates than between monkeys. As
the biological replicates analysis included both male and
female monkeys, sex was included as a fixed effect in the
model.
Differential gene expression analysis
Probes that are differentially expressed in brain regions in
tissue set one were determined using the limma package
(42) of the Bioconductor project, a linear modeling approach
that uses an empirical Bayes method in which the t-statistic
standard errors have been moderated across probes. This pro-
cedure effectively borrows information from the ensemble of
probes to aid with inference about each individual probe
(43). The correlation of repeated measures from the same
vervet was addressed using a version of a mixed model analy-
sis that again borrows information across probes (42). All
pairwise contrasts between the nine tissues (eight brain
regions and blood) were assessed. The false-discovery rate pro-
cedure was used to control for multiple testing. Only probes that
were detected in all twelve individuals in all available brain and
blood samples were examined for differential expression.
The number of genes that were differentially expressed
between a pair of tissues in tissue set one was used as a dis-
tance metric, and hierarchical clustering, using complete
linkage (44), was applied to this distance matrix to cluster
tissues. This clustering analysis used only probes that were
detected in all 12 individuals in all brain and blood samples.
Probes that were not detected in some tissues would not be
used in the cluster analysis, yet these probes may provide
interesting information on differences among tissues. Further
comparisons of expression in different brain tissues were per-
formed with all 22 184 probes, using, as a distance metric, the
number of differentially detected probes in the two tissues.
A probe was considered to be differentially detected in two
tissues, if the number of animals in which the probe was
detected (based on the above described Illumina detection cri-
teria) in one tissue was less than two and the number of
animals in the other tissue was nine or more. Probes detected
in three to eight individuals in either of the two tissues being
compared were not considered differentially detected.
Heritability estimates
Heritability of gene expression in blood of selected transcripts
was estimated with data from 347 subjects from the extended
vervet pedigree (tissue set three), using a variance component
analysis method as implemented in SOLAR (45). Sex, age and
sample grouping during microarray experiment (batch) were
included as covariates.
Functional category enrichment analysis
Functional category enrichment analysis was performed using
the Panther classification tool (http://www.pantherdb.org/)
(46). Briefly, this tool maps the gene list of interest to the
Panther ontology and compares to the selected reference
gene list to identify over- and under-represented terms. The
expected value is determined as the number of genes that
are expected in the gene list for a given Panther category,
based on the term incidence in the reference list. Total of
17 253 of 18 189 HumanRef-8 v2 chip genes were represented
in the Panther ontology and we used them as a reference gene
list for comparison with lists of selected genes. P-values of
binomial statistic were obtained for Panther classification cat-
egories for each molecular function, biological process and
pathway term. Bonferroni correction was applied to correct
for multiple testing. Owing to sequence incompatibilities in
cross-species hybridization, the lists of genes selected based
on gene expression measures may be biased against rapidly
evolving genes and therefore functional categories attributable
to such genes may appear as underrepresented in our analysis.
Sequencing of probe interacting region
Genomic DNA from 12 monkeys used for gene expression com-
parison between brain and blood was used to sequence probe
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interacting region in 16 heritable transcripts (Table 2). A standard
sequencing procedure with BigDye Terminator v3.1 was used to
sequence PCR amplicons.
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Supplementary Material is available at HMG online.
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